Novasys Medical - Management

Novasys Medical, Inc. has a solid team of people dedicated to improving the quality of life for women. We have an experienced management team and an active, experienced Board of Directors.

Scott Cramer
President and Chief Executive Officer
Scott has over 20 years of experience in general management and sales and sales management with medical device companies. Prior to joining Novasys, Scott was President and CEO of Bacchus Vascular, Inc., a company dedicated to the treatment of peripheral vascular disease. Scott successfully negotiated the sale of Bacchus to Covidien in 2009. Previously, Scott was the Senior Vice President of U.S. Sales and Account Services for VNUS, having joined VNUS in October 2000 as the Vice President of North American Sales. From July 1997 to September 2000, Mr. Cramer led the sales function at EndoSonics Corporation, a cardiovascular device company, most recently as Vice President U.S. Sales. From February 1996 to July 1997, Mr. Cramer served first as the Eastern Region Manager and then as the National Sales Manager at Cardiometrics, Inc., a medical device company. From June 1990 to December 1995, Mr. Cramer held several positions at Baxter Healthcare Corporation's cardiovascular division.

Mr. Cramer holds a B.S. degree in Finance from the Philadelphia University.

Mike has over 20 years of experience in the medical device industry. He most recently served as the Chief Financial Officer of Baxano, Inc., an orthopedic company with an innovative solution to lower lumbar stenosis, where he secured a $30M financing with an outside lead. Prior to Baxano, Mike was CFO at Bacchus Vascular, a company focused on the treatment of Deep Vein Thrombosis, which was acquired by Covidien in early 2009. Prior to Bacchus, Mike served as the Controller at Lipid Sciences, a closely held public company, and was also with Kerberos Proximal Solutions leading up to its acquisition by Foxhollow Corporation. Mike was the Chief Financial Officer of Solarant Medical for eight years, where he was a member of the company’s founding management team. Mike began his career in medical devices with Guidant (formerly Advanced Cardiovascular Systems) where for nearly 10 years he held various management positions in Operations, Marketing, and Finance. Mike holds a B.S. in Finance from California State University, Long Beach, and earned his M.B.A. from California State University, Fullerton.

Dr. Alagia is a Board Certified Obstetrician and Gynecologist and a Fellow of both the American College of Surgeons and American College of Obstetricians and Gynecologists. In addition to his extensive clinical experience in practice building and medical devices, Dr. Alagia was the founding program director for the Minimally Invasive Surgery program at the George Washington University Hospital. During his time in clinical and academic practice Dr Alagia worked closely as a subject matter expert with Ethicon Women's Health and Urology, contributing significantly to the professional education program for gynecologic surgeons interested in developing skills using minimally invasive surgical instruments for hospital, ASC and office based use. Prior to joining Novasys Dr Alagia was the President of Safe Sedation, an anesthesia service provider to non-hospital based ambulatory surgical centers and physician offices where he was responsible for business development and physician - corporate relations.

Dr Alagia received his undergraduate degree in biology and genetics from Georgetown University and his Medical Degree from the same institution. After completing three years of general surgical residency at the University of Louisville he then transferred his surgical training to Georgetown University where he completed his residency training in Obstetrics and Gynecology. After completing an MBA in finance from the Johns Hopkins University in Baltimore, Maryland, Dr. Alagia has engaged in both entrepreneurial and political activities focused on empowering physicians and their practices in an ever changing healthcare environment.

Mary has over 25 years of experience in the healthcare industry, ranging from hospital administration and health plan operation to managed care contracting with major payers. Prior to Novasys, Mary was the Vice President of Clinical Research, Reimbursement & Compliance for Endocare, Inc., a urology-focused medical device firm. While at Endocare, she obtained coverage from major private payers and increased reimbursement from Medicare. Prior to Endocare, she held Vice President positions at PacifiCare/UnitedHealthcare and Matria Healthcare in Contracting and Development respectively. Mary graduated magna cum laude with a B.A. in History and Economics and has a Masters degree in Policy Analysis and Administration from the University of South Carolina.

Simon has over 22 years broad-based experience in biomedical product development and manufacturing (both single-use probes/sensors/catheters and capital equipment) with Tyco Healthcare (Nellcor), GE/Marquette (Corometrics), Novametrix Medical Systems and Physiological Instrumentation (a UK-based start-up). In addition to product development, Simon has extensive experience including clinical studies/biostatistics, regulatory strategy/submissions, intellectual property and manufacturing engineering. Prior to joining Novasys Medical in 2001, he led Nellcor's technical, clinical and regulatory functions in obtaining PMA approval of a breakthrough OB/GYN product. Simon's experience ranges from being the first R&D employee at a start-up to holding the position of Vice President of Engineering at Corometrics, leading a department of 55. Simon obtained his Bachelor of Science with Honors in Physics from Imperial College of Science and Technology in London.

Lauri Campbell
Vice President of Marketing
Lauri joined Novasys Medical with 17 years experience in medical device marketing and sales management in both Fortune 100 and small venture-backed start-up companies. Most recently, she was an independent marketing consultant assisting small companies in launching new products in the sleep disorders, gastroenterology and cardiology markets. Prior to that, Lauri held marketing management positions at Neoforma, a publicly held Internet start-up serving the health care market. Lauri spent three years with Johnson & Johnson’s orthopaedics business unit, serving as Area Manager and Territory General Manager and successfully integrating the J&J and DePuy sales organizations in Northern California after J&J’s acquisition of DePuy. Previously, Lauri held a variety of marketing and product management positions at Abbott Laboratories and Nellcor, where she led the worldwide marketing activities for an $80 million disposable and reusable sensor product line. Lauri has served on the Board of Directors of the Professional Women’s Healthcare Alliance, a non-profit networking organization serving women in the pharmaceutical, biotech and medical device industry, and she was recently named to the Board of Directors as Industry Council Chair for the National Association for Continence, the nation’s largest patient advocacy organization for people suffering from incontinence. Lauri holds a B.A. from the University of California at Los Angeles, and an MBA from the Stanford Graduate School of Business.

Novasys US Sales currently handled by President and CEO, Scott Cramer

Scott Cramer (President and CEO, Novasys Medical, Inc.)
Douglas Kelly, MD (Alloy Ventures)
Ray Larkin, Jr., Chairman (Industry Representative)
Richard Lin (Three Arch Partners)
Randy Lindholm (Industry Representative)
Beckie Robertson (Versant Ventures)
Steve Sullivan, MD (Skyline Ventures)

Affinity Capital Management
Delphi Ventures
GBS Venture Partners
Hercules Technology Growth Capital, Inc.
INVESCO Private Capital
JPMorgan Partners (managed by Panorama Capital)
ONSET Ventures

	Novasys Medical, Inc. has a solid team of people dedicated to improving the quality of life for women. We have an experienced management team and an active, experienced Board of Directors.
	Scott Cramer President and Chief Executive Officer Scott has over 20 years of experience in general management and sales and sales management with medical device companies. Prior to joining Novasys, Scott was President and CEO of Bacchus Vascular, Inc., a company dedicated to the treatment of peripheral vascular disease. Scott successfully negotiated the sale of Bacchus to Covidien in 2009. Previously, Scott was the Senior Vice President of U.S. Sales and Account Services for VNUS, having joined VNUS in October 2000 as the Vice President of North American Sales. From July 1997 to September 2000, Mr. Cramer led the sales function at EndoSonics Corporation, a cardiovascular device company, most recently as Vice President U.S. Sales. From February 1996 to July 1997, Mr. Cramer served first as the Eastern Region Manager and then as the National Sales Manager at Cardiometrics, Inc., a medical device company. From June 1990 to December 1995, Mr. Cramer held several positions at Baxter Healthcare Corporation's cardiovascular division. Mr. Cramer holds a B.S. degree in Finance from the Philadelphia University.
	Michael Gandy Chief Financial Officer Mike has over 20 years of experience in the medical device industry. He most recently served as the Chief Financial Officer of Baxano, Inc., an orthopedic company with an innovative solution to lower lumbar stenosis, where he secured a $30M financing with an outside lead. Prior to Baxano, Mike was CFO at Bacchus Vascular, a company focused on the treatment of Deep Vein Thrombosis, which was acquired by Covidien in early 2009. Prior to Bacchus, Mike served as the Controller at Lipid Sciences, a closely held public company, and was also with Kerberos Proximal Solutions leading up to its acquisition by Foxhollow Corporation. Mike was the Chief Financial Officer of Solarant Medical for eight years, where he was a member of the company’s founding management team. Mike began his career in medical devices with Guidant (formerly Advanced Cardiovascular Systems) where for nearly 10 years he held various management positions in Operations, Marketing, and Finance. Mike holds a B.S. in Finance from California State University, Long Beach, and earned his M.B.A. from California State University, Fullerton.
	Damian P. "Pat" Alagia III, M.D. Medical Director and Vice President of Medical Affairs Dr. Alagia is a Board Certified Obstetrician and Gynecologist and a Fellow of both the American College of Surgeons and American College of Obstetricians and Gynecologists. In addition to his extensive clinical experience in practice building and medical devices, Dr. Alagia was the founding program director for the Minimally Invasive Surgery program at the George Washington University Hospital. During his time in clinical and academic practice Dr Alagia worked closely as a subject matter expert with Ethicon Women's Health and Urology, contributing significantly to the professional education program for gynecologic surgeons interested in developing skills using minimally invasive surgical instruments for hospital, ASC and office based use. Prior to joining Novasys Dr Alagia was the President of Safe Sedation, an anesthesia service provider to non-hospital based ambulatory surgical centers and physician offices where he was responsible for business development and physician - corporate relations. Dr Alagia received his undergraduate degree in biology and genetics from Georgetown University and his Medical Degree from the same institution. After completing three years of general surgical residency at the University of Louisville he then transferred his surgical training to Georgetown University where he completed his residency training in Obstetrics and Gynecology. After completing an MBA in finance from the Johns Hopkins University in Baltimore, Maryland, Dr. Alagia has engaged in both entrepreneurial and political activities focused on empowering physicians and their practices in an ever changing healthcare environment.
	Mary Syiek Vice President of Reimbursement and Compliance Mary has over 25 years of experience in the healthcare industry, ranging from hospital administration and health plan operation to managed care contracting with major payers. Prior to Novasys, Mary was the Vice President of Clinical Research, Reimbursement & Compliance for Endocare, Inc., a urology-focused medical device firm. While at Endocare, she obtained coverage from major private payers and increased reimbursement from Medicare. Prior to Endocare, she held Vice President positions at PacifiCare/UnitedHealthcare and Matria Healthcare in Contracting and Development respectively. Mary graduated magna cum laude with a B.A. in History and Economics and has a Masters degree in Policy Analysis and Administration from the University of South Carolina.
	Simon Thomas R&D, RA/QA and Operations Simon has over 22 years broad-based experience in biomedical product development and manufacturing (both single-use probes/sensors/catheters and capital equipment) with Tyco Healthcare (Nellcor), GE/Marquette (Corometrics), Novametrix Medical Systems and Physiological Instrumentation (a UK-based start-up). In addition to product development, Simon has extensive experience including clinical studies/biostatistics, regulatory strategy/submissions, intellectual property and manufacturing engineering. Prior to joining Novasys Medical in 2001, he led Nellcor's technical, clinical and regulatory functions in obtaining PMA approval of a breakthrough OB/GYN product. Simon's experience ranges from being the first R&D employee at a start-up to holding the position of Vice President of Engineering at Corometrics, leading a department of 55. Simon obtained his Bachelor of Science with Honors in Physics from Imperial College of Science and Technology in London.
	Lauri Campbell Vice President of Marketing Lauri joined Novasys Medical with 17 years experience in medical device marketing and sales management in both Fortune 100 and small venture-backed start-up companies. Most recently, she was an independent marketing consultant assisting small companies in launching new products in the sleep disorders, gastroenterology and cardiology markets. Prior to that, Lauri held marketing management positions at Neoforma, a publicly held Internet start-up serving the health care market. Lauri spent three years with Johnson & Johnson’s orthopaedics business unit, serving as Area Manager and Territory General Manager and successfully integrating the J&J and DePuy sales organizations in Northern California after J&J’s acquisition of DePuy. Previously, Lauri held a variety of marketing and product management positions at Abbott Laboratories and Nellcor, where she led the worldwide marketing activities for an $80 million disposable and reusable sensor product line. Lauri has served on the Board of Directors of the Professional Women’s Healthcare Alliance, a non-profit networking organization serving women in the pharmaceutical, biotech and medical device industry, and she was recently named to the Board of Directors as Industry Council Chair for the National Association for Continence, the nation’s largest patient advocacy organization for people suffering from incontinence. Lauri holds a B.A. from the University of California at Los Angeles, and an MBA from the Stanford Graduate School of Business.
	Novasys US Sales currently handled by President and CEO, Scott Cramer

	Scott Cramer (President and CEO, Novasys Medical, Inc.) Douglas Kelly, MD (Alloy Ventures) Ray Larkin, Jr., Chairman (Industry Representative) Richard Lin (Three Arch Partners) Randy Lindholm (Industry Representative) Beckie Robertson (Versant Ventures) Steve Sullivan, MD (Skyline Ventures) Affinity Capital Management Delphi Ventures GBS Venture Partners Hercules Technology Growth Capital, Inc. INVESCO Private Capital JPMorgan Partners (managed by Panorama Capital) ONSET Ventures
	Home \| About Renessa® \| Clinical \| News \| Leadership \| Contact Us \| Legal Disclaimer Copyright © 2010 Novasys Medical, Inc. All Rights Reserved.